BioSpace News Archive

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that President and Chief Executive Officer Brad Mason will present at the Jefferies 2019 Healthcare Conference in New York on Thursday, June 6, 2019 at 1:30 p.m. ET.

Novel vector, 4D-C102, demonstrates superior performance compared to commonly used AAV1, AAV8, and AAV9

Eli Lilly and Company will participate in the Goldman Sachs 40th Annual Global Healthcare Conference on Wednesday, June 12, 2019.

Today eHealth, Inc. (NASDAQ: EHTH) (eHealth.com) released results from a survey of health insurance companies touching on enrollment trends, public policy issues, and the politics of health care in the United States.

ITI’s technology platform has the potential to utilize the body’s natural biochemistry to develop a broad immune response and is currently being employed in a Phase II clinical trial as a cancer immunotherapy.

The Company’s management will be participating in the 39th Annual William Blair Growth Stock Conference in Chicago.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Indivior PLC from March 10, 2015 through April 9, 2019, inclusive (the “Class Period”) of the important June 24, 2019 lead plaintiff deadline in the securities class action filed by the firm

IQVIA™ (NYSE:IQV) is pleased to have provided support towards the approval from the U.S. Food and Drug Administration to expand the indications for IBRANCE® (palbociclib) in combination with an aromatase inhibitor or fulvestrant to include the treatment of men with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer

Wetteny Joseph, Senior Vice President & Chief Financial Officer, will present at the Jefferies Healthcare Conference at 3:00 p.m. ET on Thursday, June 6, 2019 in New York, NY.

Submissions can be submitted until Aug. 1